Survey/NN
of/IN
the/DT
Applications/NNS
of/IN
NGS/NN
to/TO
Whole-Genome/VB
Sequencing/NN
and/CC
Expression/NN
Profiling/JJ
./.
====================
Recently/RB
,/,
the/DT
technologies/NNS
of/IN
DNA/NN
sequence/NN
variation/NN
and/CC
gene/NN
expression/NN
profiling/VBG
have/VBP
been/VBN
used/VBN
widely/RB
as/IN
approaches/NNS
in/IN
the/DT
expertise/NN
of/IN
genome/NN
biology/NN
and/CC
genetics/NNS
./.
====================
The/DT
application/NN
to/TO
genome/NN
study/NN
has/VBZ
been/VBN
particularly/RB
developed/VBD
with/IN
the/DT
introduction/NN
of/IN
the/DT
next-generation/NN
DNA/NN
sequencer/NN
(/(
NGS/NN
)/)
Roche/454/NN
and/CC
Illumina/Solexa/NN
systems/NNS
,/,
along/IN
with/IN
bioinformation/NN
analysis/NN
technologies/NNS
of/IN
whole-genome/DT
de/FW
novo/FW
assembly/NN
,/,
expression/NN
profiling/VBG
,/,
DNA/NN
variation/NN
discovery/RB
,/,
and/CC
genotyping/VBG
./.
====================
Both/DT
massive/JJ
whole-genome/WP$
shotgun/JJ
paired-end/NN
sequencing/NN
and/CC
mate/VBP
paired-end/NN
sequencing/NN
data/NNS
are/VBP
important/JJ
steps/NNS
for/IN
constructing/VBG
de/FW
novo/FW
assembly/NN
of/IN
novel/JJ
genome/NN
sequencing/NN
data/NNS
./.
====================
It/PRP
is/VBZ
necessary/JJ
to/TO
have/VB
DNA/NN
sequence/NN
information/NN
from/IN
a/DT
multiplatform/JJ
NGS/NN
with/IN
at/IN
least/JJS
2×/CD
and/CC
30×/CD
depth/NN
sequence/NN
of/IN
genome/NN
coverage/VBP
using/VBG
Roche/454/NN
and/CC
Illumina/Solexa/NN
,/,
respectively/RB
,/,
for/IN
effective/JJ
an/DT
way/NN
of/IN
de/FW
novo/FW
assembly/NN
./.
====================
Massive/JJ
short-length/JJ
reading/NN
data/NNS
from/IN
the/DT
Illumina/Solexa/NN
system/NN
is/VBZ
enough/IN
to/TO
discover/JJ
DNA/NN
variation/NN
,/,
resulting/VBG
in/IN
reducing/VBG
the/DT
cost/JJ
of/IN
DNA/NN
sequencing/NN
./.
====================
Whole-genome/DT
expression/NN
profile/NN
data/NNS
are/VBP
useful/JJ
to/TO
approach/VB
genome/NN
system/NN
biology/NN
with/IN
quantification/NN
of/IN
expressed/VBN
RNAs/NNS
from/IN
a/DT
whole-genome/JJ
transcriptome/VBP
,/,
depending/VBG
on/IN
the/DT
tissue/NN
samples/NNS
./.
====================
The/DT
hybrid/NN
mRNA/NN
sequences/NNS
from/IN
Rohce/454/NN
and/CC
Illumina/Solexa/NN
are/VBP
more/RBR
powerful/JJ
to/TO
find/VB
novel/JJ
genes/NNS
through/IN
de/FW
novo/FW
assembly/NN
in/IN
any/DT
whole-genome/JJ
sequenced/VBN
species/NNS
./.
====================
The/DT
20×/CD
and/CC
50×/CD
coverage/NN
of/IN
the/DT
estimated/VBN
transcriptome/JJ
sequences/NNS
using/VBG
Roche/454/NN
and/CC
Illumina/Solexa/NN
,/,
respectively/RB
,/,
is/VBZ
effective/JJ
to/TO
create/VB
novel/JJ
expressed/VBN
reference/VBP
sequences/NNS
./.
====================
However/RB
,/,
only/RB
an/DT
average/NN
30×/CD
coverage/NN
of/IN
a/DT
transcriptome/JJ
with/IN
short/JJ
read/VBN
sequences/NNS
of/IN
Illumina/Solexa/NN
is/VBZ
enough/IN
to/TO
check/VB
expression/NN
quantification/NN
,/,
compared/VBN
to/TO
the/DT
reference/NN
expressed/VBN
sequence/NN
tag/NN
sequence/NN
./.
====================
Scientists/NNS
have/VBP
tried/VBN
to/TO
understand/VB
biology/NN
through/IN
DNA/NN
sequence/NN
information/NN
,/,
since/IN
the/DT
DNA/NN
is/VBZ
verified/VBN
as/IN
the/DT
unit/NN
of/IN
genetic/JJ
heredity/NN
./.
====================
Also/RB
,/,
scientists/VBZ
hope/NN
to/TO
dramatically/RB
reduce/VBP
the/DT
cost/JJ
of/IN
reading/VBG
genomic/JJ
DNA/NN
and/CC
to/TO
obtain/VB
the/DT
high-throughput/JJ
DNA/NN
sequence/NN
information/NN
./.
====================
Since/IN
the/DT
automated/JJ
DNA/NN
sequencers/NNS
were/VBD
developed/VBN
with/IN
fluorescent/JJ
dyes/NNS
of/IN
different/JJ
colors/NNS
,/,
laser/RB
,/,
and/CC
computer/NN
technology/NN
in/IN
the/DT
1980s/NNS
,/,
the/DT
human/JJ
genome/NN
project/VB
(/(
HGP/NN
)/)
was/VBD
begun/VBN
in/IN
1990/CD
,/,
and/CC
the/DT
human/JJ
genome/NN
was/VBD
completely/RB
released/VBN
in/IN
2003/CD
,/,
while/IN
further/RBR
analysis/NN
is/VBZ
still/RB
being/VBG
published/VBN
./.
====================
A/DT
total/JJ
of/IN
about/RB
3/CD
billion/NN
dollars/VBZ
was/VBD
invested/VBN
to/TO
the/DT
project/NN
./.
====================
In/IN
1991/CD
,/,
the/DT
National/JJ
Human/JJ
Genome/NN
Research/NN
Institute/JJ
(/(
NHGRI/NN
)/)
funds/VBZ
were/VBD
geared/VBN
toward/IN
lowering/JJ
the/DT
cost/JJ
of/IN
DNA/NN
sequencing/NN
./.
====================
Some/DT
of/IN
technologies/NNS
invested/VBN
improved/VBD
the/DT
DNA/NN
sequencing/NN
./.
====================
To/TO
date/NN
,/,
the/DT
Applied/JJ
Biosystems/NNS
,/,
Roche/454/NN
,/,
and/CC
Illumina/Solexa/NN
have/VBP
successfully/RB
developed/VBD
their/PRP$
technology/NN
and/CC
applied/VBD
DNA/NN
sequencing/NN
in/IN
the/DT
world/NN
during/IN
the/DT
recent/JJ
6/CD
years/NNS
./.
====================
Most/JJS
of/IN
the/DT
newest/JJS
technologies/NNS
currently/RB
in/IN
use/NN
generate/VBP
sequences/NNS
from/IN
36/CD
to/TO
1,000/CD
base/NN
pairs/NNS
,/,
which/WDT
requires/VBZ
special/JJ
software/JJ
for/IN
different/JJ
applications/NNS
,/,
including/VBG
whole-genome/JJ
sequencing/NN
,/,
transcriptome/DT
analysis/NN
,/,
and/CC
regulatory/JJ
gene/NN
analysis/NN
./.
====================
In/IN
particular/JJ
,/,
in/IN
silico/NN
method/NN
development/NN
using/VBG
bioinformation/NN
software/JJ
for/IN
next-generation/NN
sequence/NN
assembly/NN
would/MD
be/VB
alert/RB
for/IN
many/JJ
genome/NN
projects/NNS
and/CC
more/RBR
applications/NNS
in/IN
genome/NN
biology/NN
./.
====================
Particularly/RB
,/,
many/JJ
biologists/NNS
and/CC
geneticists/VBZ
using/VBG
massive/JJ
DNA/NN
and/CC
RNA/NN
sequences/NNS
have/VBP
used/VBN
the/DT
sequencing/JJ
applications/NNS
focused/VBN
on/IN
the/DT
variable/JJ
research/NN
fields/VBZ
in/IN
medicine/JJ
,/,
such/JJ
as/IN
improved/VBN
diagnosis/NN
of/IN
disease/NN
;/:
gene/NN
therapy/RB
;/:
control/JJ
systems/NNS
for/IN
drugs/NNS
,/,
including/VBG
pharmacogenomics/NNS
``/RB
custom/IN
drugs/NNS
;/:
''/RB
evolution/NN
;/:
bioenergy/RB
and/CC
environmental/JJ
applications/NNS
of/IN
creative/JJ
energy/RB
sources/NNS
(/(
biofuels/NNS
)/)
;/:
clean/RB
up/IN
of/IN
toxic/JJ
wastes/VBZ
,/,
including/VBG
efficient/JJ
environmental/JJ
sources/NNS
against/IN
carbon/JJ
;/:
and/CC
agriculture/RB
projects/VBZ
,/,
including/VBG
livestock/NN
of/IN
healthier/RB
,/,
more/RBR
productive/JJ
,/,
disease-resistant/JJ
farm/RB
animals/NNS
and/CC
breeding/VBG
of/IN
disease-/JJ
,/,
insect-/RB
,/,
and/CC
drought-resistant/JJ
crops/RB
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
report/VBP
several/JJ
ways/NNS
of/IN
genome/NN
sequencing/NN
and/CC
expression/NN
profiling/VBG
in/IN
genome/NN
biology/NN
./.
====================
Roche/454/NN
pyrosequencing/NN
technology/NN
====================
The/DT
first/JJ
high-parallel/JJ
sequencing/NN
system/NN
was/VBD
developed/VBN
with/IN
an/DT
emulsion/NN
PCR/NN
method/NN
for/IN
DNA/NN
amplification/NN
and/CC
an/DT
instrument/JJ
for/IN
sequencing/NN
by/IN
synthesis/NN
using/VBG
a/DT
pyrosequencing/JJ
protocol/NN
optimized/VBN
on/IN
the/DT
individual/JJ
well/RB
of/IN
a/DT
PicoTiterPlate/JJ
(/(
PTP/NN
)/)
[/(
1/CD
]/)
./.
====================
The/DT
DNA/NN
sequencing/NN
protocol/NN
,/,
including/VBG
sample/JJ
preparation/NN
,/,
is/VBZ
supplied/VBN
for/IN
a/DT
user/NN
to/TO
follow/VB
the/DT
method/NN
,/,
which/WDT
is/VBZ
developed/VBN
by/IN
454/CD
Life/NN
Science/NNP
(/(
now/RB
part/NN
of/IN
Roche/DT
Diagnostics/NNS
,/,
Mannheim/JJ
,/,
Germany/NNP
)/)
./.
====================
Even/RB
following/VBG
the/DT
manufacturer/NN
's/POS
protocol/NN
,/,
to/TO
obtain/VB
high-quality/JJ
DNA/NN
sequence/NN
with/IN
maximal/JJ
total/JJ
DNA/NN
sequence/NN
length/NN
as/IN
possible/JJ
,/,
one/CD
should/MD
make/VBP
a/DT
library/NN
with/IN
both/DT
adapters/NNS
on/IN
the/DT
sheared/JJ
DNA/NN
fragment/NN
and/CC
mix/JJ
the/DT
optical/JJ
ratio/NN
of/IN
library/NN
DNA/NN
versus/CC
bead/RB
for/IN
emulsion/NN
PCR/NN
./.
====================
Now/RB
,/,
the/DT
system/NN
is/VBZ
upgraded/VBN
to/TO
through-put/DT
a/DT
total/JJ
of/IN
an/DT
average/NN
of/IN
700/CD
Mbp/JJ
with/IN
an/DT
average/NN
600/CD
bp/read/RB
in/IN
one/CD
PTP/NN
run/JJ
./.
====================
The/DT
sequencer/JJ
is/VBZ
available/JJ
for/IN
single/JJ
reads/VBZ
and/CC
paired-end/NN
read/VBN
sequencing/NN
for/IN
the/DT
application/NN
of/IN
eukaryotic/JJ
and/CC
prokaryotic/JJ
whole-genome/DT
sequencing/NN
[/(
2/CD
,/,
3/CD
]/)
,/,
metagenomics/NNS
and/CC
microbial/JJ
diversity/NN
[/(
4/CD
,/,
5/CD
]/)
,/,
and/CC
genetic/JJ
variation/NN
detection/NN
for/IN
comparative/JJ
genomics/NNS
[/(
6/CD
]/)
./.
====================
Illumina/Solexa/NN
technology/NN
====================
The/DT
numerous/JJ
cost-effective/JJ
technologies/NNS
were/VBD
being/VBG
developed/VBN
for/IN
human/JJ
genome/NN
resequencing/VBG
that/DT
can/MD
be/VB
aligned/VBN
to/TO
the/DT
reference/NN
sequence/NN
[/(
7/CD
,/,
8/CD
]/)
./.
====================
The/DT
first/JJ
successful/JJ
technology/NN
to/TO
gain/VB
massive/JJ
DNA/NN
sequencing/NN
available/JJ
for/IN
resequencing/VBG
was/VBD
developed/VBN
by/IN
Solexa/NN
(/(
now/RB
part/NN
of/IN
Illumina/NN
,/,
San/NNP
Diego/NN
,/,
CA/NNP
,/,
USA/NN
)/)
./.
====================
The/DT
principle/JJ
of/IN
the/DT
system/NN
is/VBZ
the/DT
method/NN
of/IN
base-by-base/NN
sequencing/NN
by/IN
synthesis/NN
,/,
where/WRB
the/DT
sheared/JJ
template/NN
DNA/NN
is/VBZ
amplified/VBN
on/IN
the/DT
flat/JJ
surface/NN
slide/JJ
(/(
flow/NN
cell/NN
)/)
and/CC
detects/VBZ
one/CD
base/NN
on/IN
each/DT
template/NN
per/IN
cycle/NN
with/IN
four/CD
base-specific/JJ
,/,
fluorescently/RB
labeled/VBN
signals/NNS
./.
====================
Signals/NNS
for/IN
all/DT
four/CD
fluorescent/JJ
channels/NNS
are/VBP
collected/VBN
and/CC
plotted/JJ
at/IN
each/DT
position/NN
,/,
enabling/VBG
quality/NN
per/FW
scores/NNS
to/TO
be/VB
derived/VBN
using/VBG
four-color/JJ
information/NN
if/IN
desired/VBN
[/(
8/CD
]/)
./.
====================
Now/RB
,/,
a/DT
maximum/JJ
of/IN
300/CD
Gb/NN
for/IN
reading/VBG
is/VBZ
available/JJ
with/IN
101/CD
bp/NN
paired-end/NN
reading/NN
per/FW
fragment/NN
on/IN
a/DT
1-flow/JJ
cell/NN
run/NN
in/IN
the/DT
upgraded/JJ
HiSeq/JJ
system/NN
./.
====================
Novel/JJ
whole/JJ
genome/NN
de/FW
novo/FW
assembly/NN
====================
More/RBR
than/IN
11,000/CD
sequencing/NN
projects/NNS
,/,
including/VBG
targeted/VBN
projects/NNS
,/,
were/VBD
reported/VBN
on/IN
the/DT
Genome/NN
Online/NN
Database/NN
(/(
GOLD/NN
,/,
http/NN
:/:
//www.genomesonline.org/JJ
)/)
in/IN
early/JJ
2012/CD
./.
====================
Now/RB
,/,
more/RBR
than/IN
3,000/CD
genome/NN
projects/NNS
have/VBP
been/VBN
completed/VBN
on/IN
the/DT
diverse/JJ
genome/NN
species/NNS
,/,
and/CC
more/RBR
than/IN
90/CD
%/NN
of/IN
completed/VBN
projects/NNS
were/VBD
bacterial/JJ
genome/NN
sequencing/NN
./.
====================
The/DT
greatest/JJS
bacterial/JJ
genome/NN
sequencing/NN
was/VBD
performed/VBN
with/IN
454/CD
pyrosequencing/VBG
because/IN
of/IN
the/DT
available/JJ
largest/JJS
long/JJ
read/JJ
sequencing/NN
,/,
useful/JJ
for/IN
de/FW
novo/FW
assembly/NN
of/IN
novel/JJ
genome/NN
sequencing/NN
./.
====================
The/DT
official/JJ
depth/NN
of/IN
the/DT
deep/JJ
sequencing/NN
strategy/NN
of/IN
454/CD
pyrosequencing/VBG
technology/NN
for/IN
whole/JJ
bacterial/JJ
genome/NN
sequencing/NN
for/IN
de/FW
novo/FW
assembly/NN
in/IN
novel/JJ
genome/NN
sequencing/NN
is/VBZ
at/IN
least/JJS
15-20×/CD
in/IN
depth/NN
of/IN
the/DT
estimated/VBN
genome/NN
size/NN
[/(
9-13/CD
]/)
./.
====================
However/RB
,/,
Li/NNP
et/FW
al/JJ
./.
====================
[/(
3/CD
]/)
reported/VBD
that/IN
6-10×/CD
sequencing/NN
in/IN
qualified/VBN
runs/NNS
with/IN
500-bp/JJ
reads/VBZ
would/MD
be/VB
enough/RB
for/IN
de/FW
novo/FW
assemblies/NNS
from/IN
1,480/CD
prokaryote/VBP
genomes/NNS
with/IN
>/JJR
98/CD
%/NN
genome/NN
coverage/VBP
,/,
</JJR
100/CD
contigs/NNS
with/IN
N50/NN
,/,
and/CC
size/NN
>/JJR
100/CD
kb/NN
./.
====================
Recently/RB
,/,
prokaryote/VBP
whole/JJ
genome/NN
sequencing/NN
using/VBG
101/CD
bp/NN
paired-end/NN
read/VBN
data/NNS
from/IN
Illumina/Solexa/NN
systems/NNS
was/VBD
used/VBN
for/IN
de/FW
novo/FW
assembly/NN
and/CC
resequencing/VBG
./.
====================
For/IN
example/NN
,/,
a/DT
Bacillus/JJ
subtilis/NN
subspecies/NNS
genome/NN
sequence/NN
was/VBD
generated/VBN
by/IN
using/VBG
the/DT
short/JJ
read/VBN
sequence/NN
from/IN
Illumina/Solexa/NN
and/CC
assembled/VBD
with/IN
the/DT
Velvet/JJ
program/NN
[/(
14/CD
]/)
./.
====================
In/IN
this/DT
case/NN
,/,
the/DT
genome/NN
assembly/NN
was/VBD
completed/VBN
,/,
based/VBN
on/IN
the/DT
reference/NN
genome/NN
for/IN
ordering/VBG
the/DT
numerous/JJ
contigs/NNS
derived/VBN
from/IN
de/FW
novo/FW
assembly/NN
./.
====================
Even/RB
though/IN
numerous/JJ
contigs/NNS
assembled/VBN
with/IN
Illumina/Solexa/NN
data/NNS
were/VBD
produced/VBN
in/IN
the/DT
eukaryotic/JJ
genome/NN
,/,
a/DT
few/JJ
drafts/NNS
for/IN
the/DT
assembled/JJ
genome/NN
sequence/NN
were/VBD
reported/VBN
,/,
except/IN
for/IN
the/DT
giant/JJ
panda/NN
genome/NN
[/(
15/CD
]/)
,/,
which/WDT
was/VBD
covered/VBN
with/IN
assembled/VBN
contigs/NNS
(/(
2.25/CD
Gb/NN
)/)
,/,
covering/VBG
approximately/RB
94/CD
%/NN
of/IN
the/DT
expected/VBN
whole/JJ
genome/NN
./.
====================
Another/DT
example/NN
was/VBD
the/DT
woodland/NN
strawberry/JJ
genome/NN
(/(
240/CD
Mb/NN
)/)
[/(
16/CD
]/)
that/IN
was/VBD
sequenced/VBN
to/TO
39×/CD
depth/NN
of/IN
the/DT
genome/NN
,/,
assembled/VBN
de/FW
novo/FW
,/,
and/CC
anchored/JJ
to/TO
the/DT
linkage/NN
map/VBP
of/IN
seven/CD
pseudochromosomes/NNS
./.
====================
The/DT
genome/NN
sequence/NN
could/MD
be/VB
associated/VBN
with/IN
the/DT
predicted/VBN
genes/NNS
with/IN
transcriptome/JJ
sequence/NN
data/NNS
./.
====================
An/DT
ideal/JJ
method/NN
for/IN
cost-effective/JJ
novel/JJ
genome/NN
sequencing/NN
using/VBG
NGS/NN
is/VBZ
de/FW
novo/FW
assembly/NN
with/IN
diverse/JJ
shotgun/NN
fragment/NN
end/NN
sequencing/NN
data/NNS
of/IN
multiplat/JJ
systems/NNS
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
The/DT
first/JJ
strategy/NN
of/IN
novel/JJ
genome/NN
DNA/NN
sequencing/NN
is/VBZ
sequencing/JJ
the/DT
genomic/JJ
DNA/NN
for/IN
contig/NN
and/CC
scaffold/RB
construction/NN
after/IN
randomly/RB
sheared/VBN
shotgun/JJ
single/JJ
read-end/VBP
or/CC
paired-end/NN
read/RB
DNA/NN
sequencing/NN
using/VBG
Roche/454/NN
or/CC
Illumina/Solexa/NN
with/IN
information/NN
on/IN
how/WRB
to/TO
assemble/JJ
with/IN
the/DT
NGS/NN
data/NNS
using/VBG
variable/JJ
assembly/RB
software/RB
./.
====================
Recently/RB
,/,
a/DT
catfish/JJ
genome/NN
was/VBD
sequenced/VBN
with/IN
multiplatform/JJ
Roche/454/NNP
and/CC
Illumina/Solexa/FW
technology/NN
and/CC
assembled/VBD
with/IN
an/DT
effective/JJ
combination/NN
of/IN
low/JJ
coverage/JJ
depth/NN
of/IN
18×/CD
Roche/454/NNP
and/CC
70×/CD
Illumina/Solexa/NNP
data/NNS
using/VBG
3/CD
assembly/RB
softwares/VBZ
-/:
Newbler/DT
software/RB
to/TO
the/DT
454/CD
reads/VBZ
,/,
Velvet/NNP
assembler/IN
to/TO
the/DT
Illumina/NN
read/RB
,/,
and/CC
MIRA/NN
assembler/IN
for/IN
final/JJ
assembly/RB
of/IN
contigs/NNS
and/CC
singletons/NNS
derived/VBN
from/IN
initial/JJ
assembled/VBN
data/NNS
-/:
resulting/VBG
in/IN
193/CD
contigs/NNS
with/IN
an/DT
N50/NN
value/NN
of/IN
13,123/CD
bp/NN
[/(
2/CD
]/)
./.
====================
In/IN
an/DT
additional/JJ
multiplatform/JJ
data/NNS
assembly/RB
of/IN
a/DT
40-Mb/JJ
eukaryotic/JJ
genome/NN
of/IN
the/DT
fungus/JJ
Sordaria/FW
macrospra/NNS
,/,
a/DT
combination/NN
sequence/NN
of/IN
85-fold/JJ
coverage/JJ
of/IN
Illumina/Solexa/NN
and/CC
10-fold/JJ
coverage/NN
by/IN
Roche/454/NN
sequencing/NN
was/VBD
assembled/VBN
to/TO
a/DT
40-Mb/JJ
draft/RB
version/NN
(/(
N50/CD
of/IN
117/CD
kb/NN
)/)
with/IN
the/DT
Velvet/JJ
assembler/NN
as/IN
a/DT
reference/RB
of/IN
a/DT
model/NN
organism/NN
for/IN
fungal/JJ
morphogenesis/NN
[/(
17/CD
]/)
./.
====================
In/IN
the/DT
recent/JJ
effective/JJ
assembly/NN
methods/NNS
reported/VBD
,/,
combinations/NNS
of/IN
the/DT
multiplatform/JJ
sequence/NN
are/VBP
shown/VBN
as/IN
successful/JJ
novel/JJ
genome/NN
assembly/NN
using/VBG
variable/JJ
assembly/NN
strategy/NN
pipelines/NNS
./.
====================
Comparing/VBG
the/DT
pipeline/NN
of/IN
assembly/RB
strategy/NN
,/,
we/PRP
suggest/VBP
an/DT
effective/JJ
integrated/VBN
pipeline/NN
in/IN
which/WDT
data/NNS
are/VBP
filtered/VBN
to/TO
remove/VB
low-quality/JJ
and/CC
short-read/JJ
initial/JJ
assemblies/NNS
using/VBG
variable/JJ
software/RB
and/CC
then/RB
compared/VBN
to/TO
contigs/NNS
,/,
hybrid/NN
contigs/NNS
using/VBG
MIRA/NN
assembler/IN
,/,
and/CC
finally/RB
contig/NN
orders/NNS
using/VBG
SSPACE/JJ
software/RB
(/(
http/NN
:/:
//www.baseclear.com/dna-sequencing/data-analysis//JJ
)/)
[/(
18/CD
]/)
for/IN
scaffold/JJ
construction/NN
through/IN
de/FW
novo/FW
assembly/RB
of/IN
novel/JJ
genome/NN
sequencing/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
According/VBG
to/TO
the/DT
comparison/NN
of/IN
several/JJ
ways/NNS
of/IN
de/FW
novo/FW
assembly/NN
,/,
we/PRP
suggest/VBP
using/VBG
both/CC
DNA/NN
sequences/NNS
from/IN
multiplatform/JJ
NGS/NN
with/IN
at/IN
least/JJS
2×/CD
and/CC
30×/CD
depth/NN
sequences/NNS
of/IN
genome/NN
coverage/VBP
using/VBG
Roche/454/NN
and/CC
Illumina/Solexa/NN
,/,
respectively/RB
,/,
and/CC
doing/VBG
hybrid/NN
assembly/RB
for/IN
cost-effective/JJ
novel/JJ
genome/NN
sequencing/NN
./.
====================
SNP/NN
discovery/NN
and/CC
genotyping/VBG
with/IN
resequencing/VBG
====================
Resequencing/VBG
of/IN
genomic/JJ
regions/NNS
or/CC
target/NN
genes/NNS
of/IN
interest/NN
in/IN
a/DT
phenotype/NN
is/VBZ
the/DT
first/JJ
step/NN
in/IN
the/DT
detection/NN
of/IN
DNA/NN
variations/NNS
associated/VBN
with/IN
the/DT
gene/NN
regulation/NN
./.
====================
The/DT
discovery/NN
of/IN
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
including/VBG
insertion/deletions/NNS
(/(
indels/VBZ
)/)
,/,
with/IN
high-throughput/JJ
data/NNS
is/VBZ
useful/JJ
to/TO
study/VB
genetic/JJ
variation/NN
,/,
comparative/JJ
genomics/NNS
,/,
linkage/NN
map/VBP
,/,
and/CC
genomic/JJ
selection/NN
for/IN
breeding/JJ
value/NN
with/IN
DNA/NN
variation/NN
./.
====================
Many/JJ
geneticists/NNS
for/IN
biological/JJ
and/CC
genome/NN
studies/NNS
of/IN
microbial/JJ
,/,
plant/JJ
,/,
animal/JJ
,/,
and/CC
human/JJ
genomes/NNS
have/VBP
effectively/RB
used/VBN
NGS/NN
whole-genome/DT
resequencing/VBG
data/NNS
to/TO
use/VB
in/IN
variable/JJ
research/NN
fields/VBZ
,/,
such/JJ
as/IN
bacterial/JJ
evolution/NN
[/(
19/CD
]/)
,/,
genomewide/RB
analysis/NN
of/IN
mutagenesis/NN
of/IN
Escherichia/FW
coli/FW
strains/NNS
[/(
20/CD
]/)
,/,
comparative/JJ
genomics/NNS
of/IN
Streptococcus/JJ
suis/VBZ
of/IN
swine/NN
pathogen/NN
[/(
21/CD
]/)
,/,
genomic/JJ
variation/NN
effects/NNS
on/IN
phenotype/NN
and/CC
gene/NN
regulation/NN
in/IN
mouse/NN
[/(
22/CD
]/)
,/,
evolution/NN
of/IN
plant/JJ
[/(
23/CD
]/)
,/,
and/CC
comparison/NN
of/IN
genetic/JJ
variations/NNS
on/IN
the/DT
targeted/VBN
enrichment/JJ
[/(
24/CD
]/)
./.
====================
The/DT
platforms/NNS
of/IN
resequencing/VBG
projects/NNS
have/VBP
used/VBN
Illumina/Solexa/NN
of/IN
short/JJ
read/VBN
lengths/NNS
to/TO
align/VB
with/IN
the/DT
reference/NN
sequence/NN
to/TO
discover/RB
DNA/NN
variations/NNS
between/IN
compared/VBN
related/JJ
species/NNS
'/``
sequences/NNS
./.
====================
Because/IN
of/IN
rare/JJ
occurrence/NN
of/IN
SNPs/NNS
in/IN
most/JJS
species/NNS
,/,
it/PRP
is/VBZ
important/JJ
to/TO
identify/VB
high-accuracy/JJ
data/NNS
to/TO
discover/RB
DNA/NN
variations/NNS
according/VBG
to/TO
coverage/VB
depth/NN
using/VBG
MAQ/NN
(/(
http/NN
:/:
//maq.sourceforge.net/maq-man.shtml/NN
)/)
[/(
25/CD
]/)
and/CC
CLC/NN
software/RB
(/(
http/NN
:/:
//www.clcbio.com/IN
)/)
./.
====================
The/DT
public/JJ
protocol/NN
of/IN
covering/VBG
depth/NN
to/TO
discover/RB
SNPs/NNS
and/CC
indels/VBZ
on/IN
the/DT
heterogeneous/JJ
genome/NN
requires/VBZ
at/IN
least/JJS
30×/CD
of/IN
the/DT
reference/NN
genome/NN
,/,
while/IN
about/RB
10×/CD
depth/NN
of/IN
coverage/JJ
is/VBZ
enough/RB
for/IN
DNA/NN
variation/NN
study/NN
of/IN
homogeneous/JJ
genomes/NNS
./.
====================
Of/IN
course/NN
,/,
high/JJ
coverage/NN
of/IN
depth/NN
provides/VBZ
high-quality/JJ
data/NNS
in/IN
SNP/NN
detection/NN
on/IN
the/DT
reference/NN
mapping/NN
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
However/RB
,/,
short/JJ
read/VBN
lengths/NNS
of/IN
35/CD
bp/NN
or/CC
100/CD
bp/NN
show/VBP
enough/IN
to/TO
map/VB
on/IN
the/DT
reference/NN
sequence/NN
using/VBG
the/DT
MAQ/NN
software/RB
and/CC
CLC/NN
software/RB
in/IN
the/DT
genome/NN
,/,
including/VBG
short/JJ
repeated/VBN
block/VBP
regions/NNS
./.
====================
But/CC
,/,
geneticists/NNS
still/RB
require/VBP
long-read/RB
sequencing/NN
data/NNS
to/TO
distinguish/VB
repeated/VBN
block/VBP
regions/NNS
,/,
like/IN
paralogous/JJ
regions/NNS
derived/VBN
from/IN
gene/NN
duplication/NN
./.
====================
MAQ/NN
software/JJ
provides/VBZ
a/DT
consensus/NN
sequence/NN
of/IN
the/DT
genotype/NN
sequenced/VBN
of/IN
short/JJ
read/VBN
lengths/NNS
with/IN
aligned/JJ
raw/NN
reads/VBZ
to/TO
the/DT
reference/NN
sequence/NN
./.
====================
CLC/NN
software/JJ
checks/NNS
accuracy/NN
by/IN
counting/VBG
reads/VBZ
of/IN
DNA/NN
variations/NNS
of/IN
each/DT
position/NN
./.
====================
Recently/RB
,/,
a/DT
novel/JJ
application/NN
of/IN
pattern/NN
recognition/NN
for/IN
accurate/JJ
DNA/NN
variations/NNS
was/VBD
discovered/VBN
in/IN
the/DT
complexity/NN
of/IN
the/DT
genomic/JJ
region/NN
using/VBG
high-throughput/JJ
data/NNS
in/IN
a/DT
Caucasian/JJ
population/NN
[/(
26/CD
]/)
./.
====================
They/PRP
used/VBN
three/CD
independent/JJ
datasets/NNS
with/IN
Sanger/NN
sequencing/NN
and/CC
Affymetrix/JJ
and/CC
Illumina/NN
microarrays/NNS
to/TO
validate/VB
SNPs/NNS
and/CC
indels/VBZ
of/IN
a/DT
clinical/JJ
target/NN
region/NN
,/,
FKBP5/NN
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
necessary/JJ
for/IN
multiplatform/JJ
systems/NNS
to/TO
validate/VB
DNA/NN
variations/NNS
in/IN
the/DT
specific/JJ
complexity/NN
of/IN
the/DT
genome/NN
region/NN
./.
====================
Expression/NN
profiling/VBG
====================
Gene/NN
expression/NN
profiling/VBG
is/VBZ
a/DT
measurement/JJ
of/IN
the/DT
regulation/NN
of/IN
a/DT
transcriptome/JJ
from/IN
the/DT
whole/JJ
genome/NN
in/IN
the/DT
field/NN
of/IN
molecular/JJ
biology/NN
./.
====================
A/DT
conventional/JJ
method/NN
to/TO
measure/VB
the/DT
relative/JJ
activity/NN
of/IN
target/NN
genes/NNS
is/VBZ
DNA/NN
microarray/NN
technology/NN
,/,
which/WDT
estimates/VBZ
expressed/VBN
genes/NNS
with/IN
the/DT
signals/NNS
of/IN
hybridization/NN
of/IN
target/NN
genes/NNS
(/(
cDNA/NN
from/IN
mRNA/NN
)/)
on/IN
the/DT
synthesized/VBN
oligonucleotides/NNS
[/(
27/CD
]/)
./.
====================
The/DT
technology/NN
is/VBZ
still/RB
used/VBN
for/IN
functional/JJ
genomics/NNS
in/IN
the/DT
wide/JJ
era/NN
,/,
including/VBG
medicine/NN
,/,
clinic/JJ
,/,
plant/JJ
,/,
and/CC
agricultural/JJ
biotechnology/NN
[/(
28-30/CD
]/)
./.
====================
In/IN
addition/NN
,/,
microarray/NN
technology/NN
is/VBZ
also/RB
used/VBN
in/IN
the/DT
comparative/JJ
study/NN
of/IN
proteomics/NNS
and/CC
expression/NN
,/,
measuring/VBG
the/DT
level/NN
of/IN
extracellular/JJ
matrix/NN
protein/NN
[/(
30/CD
]/)
./.
====================
Since/IN
NGS/NN
technology/NN
was/VBD
developed/VBN
in/IN
2005/CD
,/,
the/DT
transcriptome/JJ
of/IN
novel/JJ
whole/JJ
genomes/NNS
could/MD
be/VB
identified/VBN
with/IN
massive/JJ
parallel/NN
mRNA/NN
sequencing/NN
using/VBG
Roche/454/NN
and/CC
Illumina/Solexa/NN
[/(
31-36/CD
]/)
./.
====================
The/DT
Roche/454/NN
system/NN
is/VBZ
more/RBR
useful/JJ
for/IN
gaining/VBG
novel/JJ
gene/NN
discovery/NN
of/IN
novel/JJ
species/NNS
'/``
genomes/NNS
for/IN
long/JJ
read/JJ
sequencing/NN
[/(
37/CD
,/,
38/CD
]/)
./.
====================
Otherwise/JJ
,/,
Illumina/Solexa/NN
is/VBZ
being/VBG
used/VBN
to/TO
profile/VB
the/DT
expression/NN
of/IN
known/VBN
genes/NNS
with/IN
mapping/VBG
short/JJ
read/VBN
sequences/NNS
to/TO
the/DT
known/JJ
reference/IN
genes/NNS
[/(
39/CD
,/,
40/CD
]/)
./.
====================
In/IN
that/DT
case/NN
,/,
rare/JJ
expressed/VBN
genes/NNS
and/CC
novel/JJ
genes/NNS
could/MD
be/VB
identified/VBN
with/IN
high-throughput/JJ
expressed/VBN
sequence/NN
tag/NN
sequences/NNS
using/VBG
Illumina/Solexa/NN
./.
====================
Also/RB
,/,
it/PRP
is/VBZ
useful/JJ
to/TO
find/VB
significant/JJ
tissue-specific/JJ
expression/NN
biases/VBZ
with/IN
comparison/NN
of/IN
transcript/NN
data/NNS
[/(
22/CD
]/)
./.
====================
Now/RB
,/,
the/DT
hybrid/NN
mRNA/NN
sequence/NN
from/IN
Rohce/454/NN
and/CC
Illumina/Solexa/NN
is/VBZ
more/RBR
powerful/JJ
for/IN
finding/NN
novel/JJ
genes/NNS
through/IN
de/FW
novo/FW
assembly/NN
in/IN
any/DT
whole-genome/JJ
species/NNS
./.
====================
The/DT
hybrid/NN
sequence/NN
data/NNS
of/IN
20×/CD
and/CC
50×/CD
coverage/VBP
of/IN
the/DT
estimated/VBN
transcriptome/JJ
sequence/NN
from/IN
Roche/454/NN
and/CC
Illumina/Solexa/NN
,/,
respectively/RB
,/,
is/VBZ
effective/JJ
in/IN
creating/VBG
novel/JJ
expressed/VBN
reference/IN
sequences/NNS
,/,
while/IN
short-read/RB
Illumina/Solexa/NN
data/NNS
are/VBP
cost-efficient/JJ
on/IN
expression/NN
quantification/NN
information/NN
for/IN
comparing/VBG
exposed/VBN
samples/NNS
and/CC
natural/JJ
phenotype/NN
samples/NNS
through/IN
mapping/VBG
to/TO
the/DT
reference/NN
genes/NNS
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
Only/RB
and/CC
average/NN
30×/CD
coverage/NN
of/IN
transcriptome/JJ
depth/NN
of/IN
short-read/JJ
sequences/NNS
of/IN
Illumina/Solexa/NN
is/VBZ
enough/IN
to/TO
check/VB
expression/NN
quantification/NN
,/,
compared/VBN
to/TO
reference/VB
expressed/VBN
sequence/NN
tag/NN
sequences/NNS
./.
====================
The/DT
expressed/VBN
information/NN
could/MD
be/VB
different/JJ
,/,
depending/VBG
on/IN
the/DT
software/JJ
using/VBG
CAP3/NN
,/,
MIRA/NN
,/,
Newbler/NN
,/,
SeqMan/NN
,/,
and/CC
CLC/NN
./.
====================
Therefore/RB
,/,
the/DT
results/NNS
should/MD
be/VB
compared/VBN
according/VBG
to/TO
variable/JJ
program/NN
options/NNS
to/TO
define/VB
robust/JJ
expression/NN
profiling/VBG
[/(
41/CD
]/)
./.
====================
To/TO
date/NN
,/,
a/DT
powerful/JJ
tool/NN
of/IN
ChIP-on-chip/NN
is/VBZ
used/VBN
for/IN
understanding/VBG
gene/NN
transcription/NN
regulation/NN
./.
====================
Thus/RB
,/,
two-channel/JJ
microarray/NN
technology/NN
of/IN
a/DT
combination/NN
of/IN
chromatin/NN
immunoprecipitation/NN
could/MD
be/VB
used/VBN
for/IN
genomewide/NN
mapping/VBG
of/IN
binding/VBG
sites/NNS
of/IN
DNA-interacting/JJ
proteins/NNS
[/(
29/CD
]/)
./.
====================
In/IN
any/DT
NGS/NN
application/NN
,/,
the/DT
transcriptome/JJ
expression/NN
information/NN
would/MD
be/VB
more/RBR
useful/JJ
than/IN
complete/JJ
genome/NN
information/NN
research/NN
with/IN
the/DT
lowest/JJS
sequencing/NN
budget/NN
for/IN
biologists/NNS
to/TO
better/RBR
understand/VB
gene/NN
regulation/NN
of/IN
related/JJ
genetic/JJ
phenotypes/NNS
with/IN
the/DT
in/FW
silico/NN
method/NN
./.
====================
Of/IN
in/IN
silico/NN
methods/NNS
,/,
conserved/VBN
miRNA/NN
and/CC
novel/JJ
miRNA/NN
discovery/NN
is/VBZ
available/JJ
on/IN
the/DT
massive/JJ
miRNAnome/NN
data/NNS
in/IN
any/DT
species/NNS
./.
====================
Specially/RB
,/,
the/DT
target/NN
genes/NNS
of/IN
miRNA/JJ
discovered/VBN
could/MD
be/VB
robust/JJ
information/NN
to/TO
approach/VB
genome/NN
biology/NN
studies/NNS
./.
====================
Transcriptome/DT
assembly/NN
is/VBZ
smaller/JJR
than/IN
genome/NN
assembly/NN
and/CC
thus/RB
should/MD
be/VB
more/RBR
computationally/RB
tractable/JJ
but/CC
is/VBZ
often/RB
harder/VBP
,/,
as/IN
individual/JJ
contigs/NNS
can/MD
often/RB
have/VBP
highly/RB
variable/JJ
read/VBN
coverages/VBZ
./.
====================
Comparing/VBG
single/JJ
assemblers/NNS
,/,
Newbler/NN
2.5/CD
performed/VBN
the/DT
best/JJS
on/IN
our/PRP$
trial/NN
dataset/NN
,/,
but/CC
other/JJ
assemblers/NNS
were/VBD
closely/RB
comparable/JJ
./.
====================
Combining/VBG
different/JJ
optimal/JJ
assemblies/NNS
from/IN
different/JJ
programs/NNS
,/,
however/RB
,/,
gives/VBZ
a/DT
more/RBR
credible/JJ
final/JJ
product/NN
,/,
and/CC
this/DT
strategy/NN
is/VBZ
recommended/VBN
[/(
41/CD
]/)
./.
====================
NGS/NN
technology/NN
provides/VBZ
a/DT
cost-effective/JJ
way/NN
of/IN
sequencing/NN
for/IN
novel/JJ
whole-genome/JJ
sequencing/NN
,/,
resequencing/VBG
,/,
and/CC
expression/NN
profiling/VBG
./.
====================
Rohce/454/NN
pyrosequencing/VBG
is/VBZ
recommended/VBN
to/TO
de/FW
novo/FW
assembly/NN
of/IN
whole/JJ
prokaryote/VBP
novel/JJ
genomes/NNS
,/,
while/IN
hybrid/NN
assembly/NN
with/IN
Illumina/Solexa/NN
sequences/NNS
would/MD
be/VB
optimal/JJ
for/IN
whole/JJ
eukaryote/JJ
genomes/NNS
and/CC
transcriptome/VBP
studies/NNS
of/IN
non-model/JJ
organisms/NNS
./.
====================
Also/RB
,/,
Illumina/Solexa/NN
sequencing/NN
is/VBZ
useful/JJ
in/IN
detecting/VBG
DNA/NN
variation/NN
,/,
mapping/VBG
the/DT
short-read/JJ
resequence/NN
to/TO
the/DT
reference/NN
genome/NN
and/CC
profiling/VBG
expressed/VBN
genes/NNS
in/IN
model/NN
organisms/NNS
./.
====================
Furthermore/RB
,/,
the/DT
high-throughput/JJ
NGS/NN
sequencing/NN
enables/VBZ
us/PRP
to/TO
study/VB
with/IN
an/DT
in/FW
silico/NN
method/NN
in/IN
variable/JJ
research/NN
application/NN
fields/NNS
of/IN
molecular/JJ
genetics/NNS
,/,
including/VBG
population/NN
diversity/NN
and/CC
comparative/JJ
genomics/NNS
,/,
in/IN
a/DT
short/JJ
time/NN
./.
====================
Stringency/NN
of/IN
whole-genome/JJ
DNA/NN
shotgun/NN
sequencing/NN
for/IN
novel/JJ
genome/NN
./.
====================
Whole-genome/DT
shotgun/JJ
sequencing/NN
(/(
left/NN
of/IN
the/DT
Figure/NN
)/)
for/IN
contig/NN
construction/NN
:/:
Sequencing/NN
of/IN
single-end/JJ
or/CC
paired-end/NN
fragment/NN
of/IN
whole-genome/DT
DNA/NN
shotgun/NN
library/NN
,/,
which/WDT
are/VBP
made/VBN
with/IN
the/DT
average/NN
range/NN
of/IN
200-800-bp/JJ
fragments/NNS
for/IN
Roche/454/NN
or/CC
Illumina/Solexa/NN
systems/NNS
./.
====================
In/IN
general/JJ
,/,
producing/VBG
a/DT
total/JJ
DNA/NN
sequence/NN
amount/NN
of/IN
15-20×/NN
and/CC
60×/CD
coverage/NN
in/IN
depth/NN
of/IN
a/DT
genome/NN
depends/VBZ
on/IN
using/VBG
Roche/454/NN
or/CC
Illumina/Solexa/NN
,/,
respectively/RB
./.
====================
Whole-genome/DT
shotgun/JJ
mate/VBP
paired-end/NN
sequencing/NN
for/IN
scaffold/JJ
construction/NN
(/(
right/JJ
of/IN
the/DT
Figure/NN
)/)
:/:
sequencing/VBG
of/IN
the/DT
mate/JJ
paired-end/NN
fragments/NNS
of/IN
the/DT
whole-genome/JJ
DNA/NN
shotgun/NN
library/NN
,/,
which/WDT
are/VBP
made/VBN
with/IN
the/DT
average/NN
range/NN
of/IN
2-40-Kb/JJ
fragments/NNS
for/IN
next-generation/JJ
DNA/NN
sequencer/NN
./.
====================
The/DT
sequencing/NN
amount/NN
of/IN
more/RBR
than/IN
20×/CD
coverage/NN
in/IN
depth/NN
of/IN
the/DT
genome/NN
is/VBZ
effective/JJ
for/IN
scaffold/JJ
constructions/NNS
./.
====================
Integrated/JJ
pipeline/NN
for/IN
de/FW
novo/FW
assembly/NN
of/IN
novel/JJ
genome/NN
sequencing/NN
./.
====================
The/DT
scheme/NN
is/VBZ
filtering/JJ
data/NNS
to/TO
remove/VB
low-quality/JJ
and/CC
shot-read/JJ
initial/JJ
assemblies/NNS
using/VBG
variable/JJ
software/JJ
and/CC
compare/VBP
to/TO
contigs/NNS
,/,
hybrid/NN
contigs/NNS
using/VBG
MIRA/NN
assembler/NN
,/,
and/CC
contig/NN
ordering/VBG
using/VBG
SSPACE/JJ
software/RB
to/TO
scaffold/JJ
construction/NN
./.
====================
View/NN
of/IN
single/JJ
nucleotide/NN
polymorphism/NN
(/(
SNP/NN
)/)
discovery/NN
through/IN
mapping/NN
short/JJ
reads/VBZ
from/IN
Illumina/Solexa/NN
to/TO
reference/VB
sequence/NN
on/IN
MAQ/NN
software/JJ
(/(
A/DT
)/)
and/CC
CLC/NN
software/JJ
(/(
B/NN
)/)
./.
====================
(/(
A/NN
)/)
Short/NN
read/VBN
35/CD
bp/NN
per/FW
read/VBD
of/IN
soybean/JJ
genome/NN
shows/VBZ
completely/RB
mapped/VBD
on/IN
the/DT
soybean/JJ
reference/VBP
sequence/NN
./.
====================
The/DT
MAQ/NN
software/JJ
provides/VBZ
a/DT
consensus/NN
sequence/NN
of/IN
the/DT
genotype/NN
sequenced/VBN
of/IN
short/JJ
read/VBN
lengths/NNS
with/IN
aligned/JJ
raw/NN
reads/VBZ
to/TO
the/DT
reference/NN
sequence/NN
./.
====================
(/(
B/NN
)/)
CLC/NN
software/JJ
is/VBZ
useful/JJ
for/IN
counting/NN
reads/VBZ
with/IN
DNA/NN
variations/NNS
at/IN
each/DT
position/NN
./.
====================
A/DT
scheme/JJ
of/IN
transcriptome/JJ
expression/NN
analysis/NN
through/IN
massively/RB
parallel/JJ
signature/NN
sequencing/NN
(/(
MPSS/NNS
)/)
technology/NN
and/CC
bioinformatics/NNS
:/:
The/DT
identification/NN
of/IN
expressed/VBN
genes/NNS
through/IN
hybrid/NN
de/FW
novo/FW
assembly/NN
with/IN
Roche/454/NN
and/CC
Illumina/Solexa/NN
data/NNS
(/(
left/NN
)/)
and/CC
expressed/VBD
level/NN
profiling/VBG
through/IN
mapping/VBG
the/DT
Illumina/Solexa/NN
sequence/NN
to/TO
the/DT
expressed/VBN
sequence/NN
tag/NN
reference/VBP
./.
====================
